Astrocyte phenotypes and their relationship to myelination

Journal of Anatomy

Volumn 219, Issue 1, 2011, Pages 44-52

  Nash, Besma ^a   Ioannidou, Kalliopi ^a   Barnett, Susan C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Astrocytes; Myelination; Phenotypes

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; VIMENTIN;

ALZHEIMER DISEASE; ANGIOGENESIS; ASTROCYTE; ASTROCYTOSIS; BRAIN; CELL INTERACTION; DISEASE SEVERITY; ENVIRONMENT; GLIOSIS; HOMEOSTASIS; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKODYSTROPHY; MULTIPLE SCLEROSIS; MYELIN SHEATH; MYELINATION; NERVE FIBER; NERVE FIBER REGENERATION; NONHUMAN; OLIGODENDROGLIA; PERIPHERAL NERVOUS SYSTEM; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SPINAL CORD INJURY; STEM CELL;

ANIMALS; ASTROCYTES; CELL PROLIFERATION; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; MYELIN SHEATH; OLIGODENDROGLIA; PHENOTYPE;

EID: 79958228923     PISSN: 00218782     EISSN: 14697580     Source Type: Journal    
DOI: 10.1111/j.1469-7580.2010.01330.x     Document Type: Review

References (88)

1. Albrecht PJ, Dahl JP, Stoltzfus OK, etal. (2002) Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp Neurol 173, 46-62.
2. Alexander WS (1949) Progressive fibrinoid degeneration of fibrillary astrocytes associated with menal retardation in a hydrocephalic infant. Brain 72, 373-381.
3. Back SA, Tuohy TM, Chen H, etal. (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 11, 966-972.
4. Barrett CP, Donati EG, Guth L (1984) Differences between adult and neonatal rats in their astroglial response to spinal injury. Exp Neurol 84, 374-385.
5. Bauer NG, Richter-Landsberg C, ffrench-Constant C (2009) Role of the oligodendrocyte cytoskeleton in differentiation and myelination. Glia 57, 1790-1801.
6. Bitsch A, Schuchardt J, Bunkowski S, etal. (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123, 1174-1183.
7. Blakemore WK (1984) The response of oligodendrocytes to chemical injury. Acta Neurol Scand Suppl 100, 33-38.
8. Blondel O, Collin C, McCarran WJ, etal. (2000) A glia-derived signal regulating neuronal differentiation. J Neurosci 20, 8012-8020.
9. Brenner M, Johnson AB, Boespflug-Tanguy O, etal. (2001) Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 27, 117-120.
10. Bunge MB, Wood PM (2006) Transplantation of Schwann cells and olfactory ensheathing cells to promote regeneration in the CNS. In: Textbook of Neural Repair and Rehabilitation (eds Selzer ME, Clarke S, Cohen LG, Duncan PW, Gage FH), pp. 513-531. Cambridge: Cambridge University Press.
11. Cammer W, Zhang H (1999) Maturation of oligodendrocytes is more sensitive to TNF alpha than is survival of precursors and immature oligodendrocytes. J Neuroimmunol 97, 37-42.
12. Canning DR, Höke A, Malemud CJ, etal. (1996) A potent inhibitor of neurite outgrowth that predominates in the extracellular matrix of reactive astrocytes. Int J Dev Neurosci 14, 153-175.
13. Carter SL, Müller M, Manders P, etal. (2007) Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFNγ but shows differential cellular expression in experimental autoimmune encephalomolyelitis and by astrocytes and microglia in vitro. Glia 55, 1728-1739.
14. Daginakatte GC, Gadzinski A, Emnett RJ, etal. (2008) Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines. Exp Neurol 210, 261-267.
15. Dietrich J, Lacagnina M, Gass D, etal. (2005) EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy. Nat Med 11, 277-283.
16. Dziewulska D, Jamrozik Z, Podlecka A, etal. (1999) Do astrocytes participate in rat spinal cord myelination? Folia Neuropathol 37, 81-86.
17. East E, Golding JP, Phillips JB (2009) A versatile 3D culture model facilitates monitoring of astrocytes undergoing reactive gliosis. J Tissue Eng Regen Med 3, 634-646.
18. Eddleston M, Mucke L (1993) Molecular profile of reactive astrocytes - implications for their role in neurological disease. Neuroscience 54, 15-36.
19. Eng LF (1985a) Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 8, 203-214.
20. Eng LF, Vanderhaeghen JJ, Bignami A, etal. (1971) An acidic protein isolated from fibrous astrocytes. Brain Res 28, 351-354.
21. Faulkner JR, Herrmann JE, Woo MJ, etal. (2004) Reactive astrocytes protect tissue and preserve function after spinal cord injury. J Neurosci 24, 2143-2155.
22. Fawcett JW, Asher RA (1999) The glial scar and central nervous system repair. Brain Res Bull 49, 377-391.
23. Fedoroff S, White R, Neal J, etal. (1983) Astrocyte cell lineage. II. Mouse fibrous astrocytes and reactive astrocytes in cultures have vimentin- and GFP-containing intermediate filaments. Brain Res 283, 303-315.
24. Fife BT, Kennedy KJ, Paniagua MC, etal. (2001) CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 166, 7617-7624.
25. Filous AR, Miller JH, Coulson-Thomas YM, etal. (2010) Immature astrocytes promote CNS axonal regeneration when combined with chondroitinase ABC. Dev Neurobiol 70, 826-841.
26. Fitch MT, Silver J (2008) CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure. Exp Neurol 209, 294-301.
27. Franklin RJ, Crang AJ, Blakemore WF (1991) Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 20, 420-430.
28. Fujimoto Y, Yamasaki T, Tanaka N, etal. (2006) Differential activation of astrocytes and microglia after spinal cord injury in the fetal rat. Eur Spine J 15, 22-33.
29. Geren BB, Raskind J (1953) Development of the fine structure of the myelin sheath in sciatic nerves of chick embryos. Proc Natl Acad Sci USA 39, 880-884.
30. Giulian D, Woodward J, Young DG, etal. (1988) Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci 8, 2485-2490.
31. Glabinski AR, Tani M, Strieter RM, etal. (1997) Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am J Pathol 15, 617-630.
32. Godiska R, Chantry D, Dietsch GN, etal. (1995) Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol 58, 167-176.
33. Gozes I, Bassan M, Zamostiano R, etal. (1999) A novel signaling molecule for neuropeptide action: activity-dependent neuroprotective protein. Ann NY Acad Sci 897, 25-135.
34. Graça DL, Blakemore WF (1986) Delayed remyelination in rat spinal cord following ethidium bromide injection. Neuropathol Appl Neurobiol 12, 595-605.
35. Herx LM, Yong VW (2001) Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J Neuropathol Exp Neurol 60, 961-971.
36. Holley JE, Gveric D, Whatmore JL, etal. (2005) Tenascin C induces a quiescent phenotype in cultured adult human astrocytes. Glia 52, 53-58.
37. Ishibashi T, Dakin KA, Stevens B, etal. (2006a) Astrocytes promote myelination in response to electrical impulses. Neuron 49, 823-832.
38. John GR, Lee SC, Brosnan CF (2003) Cytokines: powerful regulators of glial cell activation. Neuroscientist 9, 10-22.
39. John GR, Lee SC, Song X, etal. (2005) IL-1-regulated responses in astrocytes: relevance to injury and recovery. Glia 49, 161-176.
40. Klein RS, Izikson L, Means T, etal. (2004) IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis. J Immunol 172, 550-559.
41. Krum JM, Rosenstein JM (1998) VEGF mRNA and its receptor flt-1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp Neurol 154, 57-65.
42. Larner AJ, Johnson AR, Keynes RJ (1995) Regeneration in the vertebrate central nervous system: phylogeny, ontogeny, and mechanism. Biol Rev Camb Philos Soc 70, 597-619.
43. Lassmann H (2005) Multiple sclerosis pathology: evolution of pathogenetic concepts. Brain Pathol 15, 217-222.
44. Levine JM, Reynolds R (1999) Activation and proliferation of endogenous oligodendrocytes precursor cells during ethidium bromide demyelination. Exp Neurol 160, 333-347.
45. Li R, Messing A, Goldman JE, etal. (2002) GFAP mutations in Alexander disease. Int J Dev Neurosci 20, 259-268.
46. Liberto CM, Albrecht PJ, Herx LM, etal. (2004) Pro-regenerative properties of cytokine-activated astrocytes. J Neurochem 89, 1092-1100.
47. Liedtke W, Edelmann W, Bieri PL, etal. (1996) GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17, 607-615.
48. Liu MT, Keirstead HS, Lane TE (2001) Neutralization of the chemokine CXCL10 reduces inflammatory cell invasion and demyelination and improves neurological function in a viral model of multiple sclerosis. J Immunol 167, 4091-4097.
49. Liu L, Huang D, Matsui M, etal. (2006) Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells. J Immunol 176, 4399-4409.
50. Malhotra SK, Shnitka TK (2002) Diversity in reactive astrocytes. In: Neuroglia in the Aging Brain (ed. De Vellis J), pp. 17-33. New Jersey: Humana Press.
51. Marz P, Heese K, Dimitriades-Schmutz B, etal. (1999) Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 26, 191-200.
52. Mason JL, Suzuki K, Chaplin DD, etal. (2001) Interleukin-1beta promotes repair of the CNS. J Neurosci 21, 7046-7052.
53. Meeuwsen S, Persoon-Deen C, Bsibsi M, etal. (2003) Cytokine, chemokine and growth factor gene profiling of cultured human astrocytes after exposure to proinflammatory stimuli. Glia 43, 243-253.
54. Messersmith DJ, Murtie JC, Le TQ, etal. (2000) Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 62, 241-256.
55. Michailov GV, Sereda MW, Brinkmann BG, etal. (2004) Axonal neuregulin-1 regulates myelin sheath thickness. Science 304, 700-703.
56. Moore CS, Abdullah SL, Brown A, etal. (2011) How factors secreted from astrocytes impact myelin repair. J Neurosci Res 89, 13-21.
57. Müller E (1904) Pathologische anatomie und pathogenese. In: Die Multiple (ed. Fisher G), pp. 300-344. Jena: Skleroze des Gehirns und Rückenmarks.
58. Muller M, Carer SL, Hofer MJ, etal. (2007) CXCR3 signalling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J Immunol 178, 8175-8182.
59. Nair A, Frederick TJ, Miller SD (2008) Astrocytes in multiple sclerosis: a product of their environment. Cell Mol Life Sci 65, 2702-2720.
60. Nash B, Thomson C, Linington C, etal. (in press) Differential regulation of myelination by CNTF- and tenascin-dependent effects on astrocytes. J Neurosci, [submitted].
61. Noble M, Murray K (1984) Purified astrocytes promote the in vitro division of a bipotential glial progenitor cell. EMBO J 3, 2243-2247.
62. Obayashi S, Tabunoki H, Kim SU, etal. (2009) Gene expression profiling of human neural progenitor cells following the serum-induced astrocyte differentiation. Cell Mol Neurobiol 29, 423-438.
63. Omari KM, John GR, Sealfon SC, etal. (2005) CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128, 1003-1015.
64. Pedraza L, Huang JK, Colman DR (2001) Organizing principles of the axonal axoglial apparatus. Neuron 30, 335-344.
65. Pellerin L (2005) How astrocytes feed hungry neurons. Mol Neurobiol 32, 59-72.
66. Ransohoff RM, Hamilton TA, Tani M, etal. (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 7, 592-600.
67. Redwine JM, Armstrong RC (1998) In vivo proliferation of oligodendrocyte progenitors expressing PDGF-alphaR during early remyelination. J Neurobiol 37, 413-428.
68. Redwine JM, Blinder KL, Armstrong RC (1997) In situ expression of fibroblast growth factor receptors by oligodendrocyte progenitors and oligodendrocytes in adult mouse central nervous system. J Neurosci Res 50, 229-237.
69. Ridet JL, Malhotra SK, Privat A, etal. (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci 20, 570-577.
70. Rudge JS, Silver J (1990) Inhibition of neurite outgrowth on astroglial scars in vitro. J Neurosci 10, 3594-3604.
71. Selmaj K, Raine CS (1988) Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue. Ann N Y Acad Sci 540, 568-570.
72. Sherman D, Brophy P (2005) Mechanism of axon ensheathment and myelin growth. Nat Rev Neurosci 6, 683-690.
73. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5, 146-156.
74. Sofroniew M, Vinters HV (2010) Astrocytes: biology and pathology. Acta Neuropathol 119, 7-35.
75. Sorensen A, Moffat K, Thomson C, etal. (2008) Astrocytes, but not olfactory ensheathing cells or Schwann cells, promote myelination of CNS axons in vitro. Glia 56, 750-763.
76. Talbot JF, Loy DN, Liu Y, etal. (2005) Endogenous Nkx2.2+/Olig2+ oligodendrocytes precursors cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol 192, 11-24.
77. Taveggia C, Zanazzi G, Petrylak A, etal. (2005) Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47, 681-694.
78. Tsukada N, Miyagi K, Matsuda M, etal. (1991) Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis. J Neurol Sci 104, 230-234.
79. Ullian EM, Sapperstein SK, Christopherson KS, etal. (2001) Control of synapse number by glia. Science 291, 657-661.
80. Verkhratsky A, Parpura V (2010) Recent advances in (patho)physiology of astroglia. Acta Pharmacol Sin 31, 1044-1054.
81. Villarroya H, Violleau K, Ben Younes-Chennoufi A, etal. (1996) Myelin-induced experimental allergic encephalomyelitis in Lewis rats: tumor necrosis factor alpha levels in serum and cerebrospinal fluid immunohistochemical expression in glial cells and macrophages of optic nerve and spinal cord. J Neuroimmunol 64, 55-61.
82. Watkins TA, Emery B, Mulinyawe S, etal. (2008) Distinct stages of myelination regulated by g-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60, 555-569.
83. White RE, Jakeman LB (2008) Don't fence me in: harnessing the beneficial roles of astrocytes for spinal cord repair. Restor Neurol Neurosci 26, 197-214.
84. Williams A, Piaton G, Lubetzki C (2007) Astrocytes - friends or foes in multiple sclerosis? Glia 55, 1300-1312.
85. Woodward WR, Nishi R, Meshul CK, etal. (1992) Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. J Neurosci 12, 142-152.
86. Wu E, Raine CS (1992) Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions. Lab Invest 67, 88-99.
87. Yanagisawa M, Nakashima K, Arakawa H, etal. (2000) Astrocyte differentiation of fetal neuroepithelial cells by interleukin-11 via activation of a common cytokine signal transducer, gp130, and a transcription factor, STAT3. J Neurochem 74, 1498-1504.
88. Yong VW, Moumdjian R, Yong FP, etal. (1991) Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 88, 7016-7020.